Evidence map›Paper›PMID 34733625›Full record

ArticleTranslational lung cancer research2021

Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study.

Tetsuya Sakai, Hibiki Udagawa, Keisuke Kirita, Shogo Nomura, Ryo Itotani, Yutaro Tamiya, Akira Sugimoto, Takahiro Ota, Tomoyuki Naito, Hiroki Izumi and 9 more

Open access · diamondAbstract read
In one paragraph

Article in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evolution of transbronchial needle aspiration needles: Over the last half century.Chinese medical journal pulmonary and critical care medicine · 2024
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Tetsuya SakaiDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Hibiki UdagawaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Keisuke KiritaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Shogo NomuraBiostatistics Division, Center for Research Administration and Support, National Cancer Center, Kashiwa, Japan.
Ryo ItotaniDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yutaro TamiyaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Akira SugimotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Takahiro OtaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Tomoyuki NaitoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Hiroki IzumiDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kaname NosakiDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Takaya IkedaDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Yoshitaka ZenkeDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Shingo MatsumotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Kiyotaka YohDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Seiji NihoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Tokiko NakaiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Genichiro IshiiDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Koichi GotoDepartment of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
National Cancer Center Hospital East · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is generally performed for the diagnosis of hilar/mediastinal lymph node metastasis in patients with lung cancer. Recently, a 25-gauge (G) needle became available, but robust evidence of its usefulness in routine clinical practice is still lacking.

methodsA prospective randomized crossover trial was performed, in which patients with suspected hilar/mediastinal lymph node metastasis of lung cancer underwent EBUS-TBNA. The primary endpoint was the rate of yield histology specimens containing malignant cells.

resultsFrom December 2018 to February 2020, 102 patients were randomly assigned to EBUS-TBNA using a 22G needle first, followed by a 25G needle (n=50) or EBUS-TBNA using a 25G needle first, followed by a 22G needle (n=52). There was no difference in the diagnostic yield of malignancy between the histology specimens obtained by using the 22G and 25G needles (75%

conclusionsNo significant difference in the diagnostic yield between the 22G and 25G needles was observed for the diagnosis of lymph node metastasis of lung cancer, suggesting that needles of either gauge could be used for the biopsy. However, we would recommend use of the 22G needle, because it provided larger specimens and specimens containing larger numbers of malignant cells.

trial registrationUniversity hospital Medical Information Network Clinical Trial Registry (ID: UMIN000036680).

Indexed as

bronchoscopyendobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)Lung cancerrandomized trial

Identifiers

PMID34733625
PMCPMC8512458
OpenAlexW3203363449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.